(13 Jun 2024)
RESTRICTION SUMMARY:
ASSOCIATED PRESS
Washington – 26 March 2024
1. STILL of abortion-rights activist holding a box if mifepristone in the air outside the US Supreme Court
ASSOCIATED PRESS
Tuscaloosa, Alabama – 16 March 2022
2. STILL of boxes of the drug mifepristone
ASSOCIATED PRESS
Washington – 21 May 2024
3. SOUNDBITE (English) Mark Sherman, The Associated Press:
“The Supreme Court has preserved access to the medication used in the most common form of abortion in the United States. The drug at issue, mifepristone, was used in nearly two thirds of abortions in this country in 2023. The court ruled that the anti-abortion doctors who challenged changes that the federal Food and Drug Administration made to the way mifepristone is prescribed and used, had no legal right or standing to file their lawsuit in federal court. Among the changes that the FDA made in recent years was to eliminate the need for an in-person visit and to allow the drugs to be sent by mail.”
ASSOCIATED PRESS
Washington – 26 March 2024
4. STILL of abortion-rights activist cradling a box if mifepristone
5. STILL of abortion-rights activist holding a sign outside the US Supreme Court
ASSOCIATED PRESS
Washington – 21 May 2024
6. SOUNDBITE (English) Mark Sherman, The Associated Press:
“The case is the Supreme Court’s first abortion case since the justices overruled Roe v. Wade two years ago. In that case, the court wiped away a 50-year-old ruling that had guaranteed a woman’s right to an abortion in the United States.”
ASSOCIATED PRESS
ARCHIVE: Washington – 24 June 2022
7. Various of protests outside the US Supreme Court
STORYLINE:
The Supreme Court has preserved access to a medication that was used in nearly two-thirds of all abortions in the U.S. last year.
It’s the court’s first abortion decision since conservative justices overturned Roe v. Wade two years ago.
The justices ruled Thursday that abortion opponents lacked the legal right to sue over the federal Food and Drug Administration’s approval of the medication, mifepristone, and the FDA’s subsequent actions to ease access to it.
The case had threatened to restrict access to mifepristone across the country, including in states where abortion remains legal. It’s one of two abortion cases at the high court this term.
===========================================================
Clients are reminded to adhere to all listed restrictions and to check the terms of their licence agreements. For further assistance, please contact the AP Archive on: Tel +44(0)2074827482 Email: info@aparchive.com.
Find out more about AP Archive: http://www.aparchive.com/HowWeWork
Twitter: https://twitter.com/AP_Archive
Facebook: https://www.facebook.com/APArchives
Instagram: https://www.instagram.com/APNews/
You can license this story through AP Archive: http://www.aparchive.com/metadata/youtube/a5cc7e4c176d470f83b15fa1fc6c970a
